文献速递重症综合管理与镇静镇痛

重症监护病房谵妄运动亚型的分布:一项系统性范围综述

Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review.
PubMed 文献 · Crit Care · 2022-03-03
一句话结论ICU谵妄以活动减退型最常见(50.3%),混合型谵妄持续时间、住院时间及病死率最高且接受更多药物治疗。

该系统范围综述按PRISMA-ScR和Cochrane指南在六大数据库系统检索,纳入131项研究共13,902例谵妄患者,采用随机效应模型进行荟萃回归分析。结果显示活动减退型谵妄最常见(50.3% [95% CI 46.0-54.7]),其次为混合型(27.7% [95% CI 24.1-31.3])和活动亢进型(22.7% [95% CI 19.0-26.5])。混合型谵妄患者谵妄持续时间、ICU及住院时间最长,ICU及住院病死率最高,且更常接受抗精神病药、α2受体激动剂、苯二氮䓬类和丙泊酚治疗。研究间异质性大,作者认为谵妄研究需要更标准化的方法学。

要点

  • 活动减退型谵妄是最常见的运动亚型(50.3% [95% CI 46.0-54.7]),其次为混合型(27.7% [95% CI 24.1-31.3])和活动亢进型(22.7% [95% CI 19.0-26.5])。
  • 混合型谵妄患者谵妄持续时间、ICU及住院时间最长,ICU及住院病死率最高。
  • 混合型谵妄患者更常接受抗精神病药、α2受体激动剂、苯二氮䓬类和丙泊酚治疗。
  • 在谵妄患者平均年龄>65岁的研究中,患者更可能为活动减退型谵妄。
  • 研究间异质性大,包括研究设计、场所、人群和结局报告的差异;仅少数研究贡献了次要结局,结果需谨慎解读。

适用人群与场景

  • ICU谵妄患者,纳入131项研究共13,902例谵妄患者
  • 在谵妄患者平均年龄>65岁的研究中,患者更可能为活动减退型谵妄

研究设计与关键结果

  • 研究类型:系统性范围综述,按PRISMA-ScR和Cochrane指南在六大数据库系统检索,纳入131项研究共13,902例谵妄患者,采用随机效应模型进行荟萃回归分析。
  • 活动减退型谵妄最常见(50.3% [95% CI 46.0-54.7]),其次为混合型(27.7% [95% CI 24.1-31.3])和活动亢进型(22.7% [95% CI 19.0-26.5])。
  • 混合型谵妄患者谵妄持续时间、ICU及住院时间最长,ICU及住院病死率最高,且更常接受抗精神病药、α2受体激动剂、苯二氮䓬类和丙泊酚治疗。
  • 在谵妄患者平均年龄>65岁的研究中,患者更可能为活动减退型谵妄。
  • 研究间异质性大,包括研究设计、场所、人群和结局报告的差异;仅少数研究贡献了次要结局。

证据类型、等级与局限

  • 证据类型:系统性范围综述
  • 局限:研究间异质性大,包括研究设计、场所、人群和结局报告的差异;仅少数研究贡献了次要结局,结果需谨慎解读;作者认为谵妄研究需要更标准化的方法学。

对床旁实践的改变

  • 作者认为,混合型谵妄患者谵妄持续时间、ICU及住院时间最长,ICU及住院病死率最高,且更常接受抗精神病药、α2受体激动剂、苯二氮䓬类和丙泊酚治疗。
  • 作者认为,活动减退型谵妄是最常见的运动亚型(50.3% [95% CI 46.0-54.7]),其次为混合型(27.7% [95% CI 24.1-31.3])和活动亢进型(22.7% [95% CI 19.0-26.5])。
  • 作者认为,在谵妄患者平均年龄>65岁的研究中,患者更可能为活动减退型谵妄。
  • 作者认为,研究间异质性大提示谵妄研究需要更标准化的方法学。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Delirium is the most common cerebral dysfunction in the intensive care unit (ICU) and can be subdivided into a hypoactive, hyperactive, or mixed motor subtype based on the clinical manifestation. The aim of this review was to describe the distribution, pharmacological interventions, and outcomes of delirium motor subtypes in ICU patients.

METHODS: This systematic scoping review was performed according to the PRISMA-ScR and Cochrane guidelines. We performed a systematic search in six major databases to identify relevant studies. A meta-regression analysis was performed where pooled estimates with 95% confidence intervals were computed by a random effect model.

RESULTS: We included 131 studies comprising 13,902 delirious patients. There was a large between-study heterogeneity among studies, including differences in study design, setting, population, and outcome reporting. Hypoactive delirium was the most prevalent delirium motor subtype (50.3% [95% CI 46.0-54.7]), followed by mixed delirium (27.7% [95% CI 24.1-31.3]) and hyperactive delirium (22.7% [95% CI 19.0-26.5]). When comparing the delirium motor subtypes, patients with mixed delirium experienced the longest delirium duration, ICU and hospital length of stay, the highest ICU and hospital mortality, and more frequently received administration of specific agents (antipsychotics, α2-agonists, benzodiazepines, and propofol) during ICU stay. In studies with high average age for delirious patients (> 65 years), patients were more likely to experience hypoactive delirium.

CONCLUSIONS: Hypoactive delirium was the most prevalent motor subtype in critically ill patients. Mixed delirium had the worst outcomes in terms of delirium duration, length of stay, and mortality, and received more pharmacological interventions compared to other delirium motor subtypes. Few studies contributed to secondary outcomes; hence, these results should be interpreted with care. The large between-study heterogeneity suggests that a more standardized methodology in delirium research is warranted.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. la Cour KN, Andersen-Ranberg NC, Weihe S, et al. Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review. Crit Care. 2022. PMID: 35241132. doi:10.1186/s13054-022-03931-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。